This report shows public data only. Is this your organisation? If so, login here to view your full report.

CDC Group plc

PRI reporting framework 2020

Export Public Responses
Pdf-img

You are in Direct - Fixed Income » ESG incorporation in actively managed fixed income » Implementation processes

Implementation processes

FI 01. Incorporation strategies applied

Indicate (1) Which ESG incorporation strategy and/or combination of strategies you apply to your actively managed fixed income investments; and (2) The proportion (+/- 5%) of your total actively managed fixed income investments each strategy applies to.
Corporate (financial)
0 Screening alone
0 Thematic alone
0 Integration alone
100 Screening + integration strategies
0 Thematic + integration strategies
0 Screening + thematic strategies
0 All three strategies combined
0 No incorporation strategies applied
100%
Corporate (non-financial)
0 Screening alone
0 Thematic alone
0 Integration alone
100 Screening + integration strategies
0 Thematic + integration strategies
0 Screening + thematic strategies
0 All three strategies combined
0 No incorporation strategies applied
100%

01.2. Describe your reasons for choosing a particular ESG incorporation strategy and how combinations of strategies are used.

As previously mentioned, CDC interprets “fixed income” as our entire debt portfolio and responds accordingly. ESG factors are core to all of CDC's investments. All debt opportunities are screened first against CDC's Code of Responsible Investing, including our exclusion list. The selection of remaining potential investments are benchmarked against one another and against the market for both financial and ESG factors.

Before investment, all opportunities are diligenced against international best practices, and the gap analysis is translated into an action plan which becomes part of the deal legal documents. Thus, ESG factors are explicitly and systematically included into the decision-making process.

 

01.3. Additional information [Optional].


FI 02. ESG issues and issuer research

02.1. Indicate which ESG factors you systematically research as part of your analysis on issuers.

Select all that apply
Corporate (financial)
Corporate (non-financial)
Environmental data
Social data
Governance data

02.2. Indicate what format your ESG information comes in and where you typically source it

Indicate who provides this information  

specify description

          Publicly available sources, also specialist consultancies for technical ESG information
        

Indicate who provides this information  

specify description

          Publicly available sources
        

Indicate who provides this information  

specify description

          TBC with Mark
        

Indicate who provides this information  

specific description

          Publicly available information
        

Indicate who provides this information  

02.3. Provide a brief description of the ESG information used, highlighting any differences in sources of information across your ESG incorporation strategies.

CDC gathers ESG information with respect to every investment made. ESG information is requested from prospective investees, and assessed alongside evidence from environmental and social due diligence (ESDD) documents. ESDDs are conducted either by CDC professionals or external consultants who are specialists in the particular area for diligence, and are conducted in line with international best practices.

Investment and ESG teams also incorporate wider ESG information into sector and country mapping, including, for example, inherent political risks. When a larger sector or country mapping or an assessment of a new sub-sector is being undertaken, an ESG research provider may be engaged. 

02.4. Additional information. [Optional]


FI 03. Processes to ensure analysis is robust

03.1. Indicate how you ensure that your ESG research process is robust:

specify description

          CDC internal ESG professionals review the content of all ESG-related information to ensure it is robust/accurate/appropriate.
        

03.2. Describe how your ESG information or analysis is shared among your investment team.

          Ad-hoc meetings involving all the relevant teams.
        

03.3. Additional information. [Optional]


Top